FEIBA

This brand name is authorized in Austria, Brazil, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug FEIBA contains a combination of these active pharmaceutical ingredients (APIs):

1 Factor VIII inhibitor bypass activity UNII CS849DUN3M - ANTI-INHIBITOR COAGULANT COMPLEX

Read about Factor VIII inhibitor bypass activity

2 Coagulation factor II UNII 25ADE2236L - THROMBIN

Read about Thrombin

3 Coagulation factor IX UNII 6U90Y1795T - COAGULATION FACTOR IX HUMAN

Factor IX is a single chain glycoprotein with a molecular mass of about 68,000 Dalton. It is a vitamin-K dependent coagulation factor and it is synthesised in the liver. Factor IX is activated by factor XIa in the intrinsic coagulation pathway and by the factor VII/tissue factor complex in the extrinsic pathway. Activated factor IX, in combination with activated factor VIII, activates factor X. Read about Coagulation factor IX

4 Coagulation factor X UNII 0P94UQE6SY - COAGULATION FACTOR X HUMAN

Coagulation factor X is derived from human plasma and used as a replacement for the naturally existing coagulation factor X in patients with hereditary factor X deficiency. Read about Coagulation factor X

5 Coagulation factor VII UNII 4156XVB4QD - COAGULATION FACTOR VII HUMAN

Read about Coagulation factor VII

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FEIBA Powder and solvent for solution for infusion	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B02BD03	Factor VIII inhibitor bypassing activity	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 501121010036917, 501121010037017, 501121010037117, 501121010037217, 501121010037317, 501121010037417, 501121010037517, 501121010037617
Country: CA	Health Products and Food Branch	Identifier(s): 02202581, 02353903
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29195-03-10
Country: EE	Ravimiamet	Identifier(s): 1021329, 1021330, 1680410, 1680421, 1680432, 1743397
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 80119
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 186799
Country: FR	Base de données publique des médicaments	Identifier(s): 67621498
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 174903, 393851, 393854, 95079
Country: HK	Department of Health Drug Office	Identifier(s): 56854, 57891
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-348186000, HR-H-682573334
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6807
Country: JP	医薬品医療機器総合機構	Identifier(s): 6343414X2058
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1000755, 1007752, 1071195, 1072764, 1080040, 1080041, 1085816, 1085817
Country: MT	Medicines Authority	Identifier(s): MA1047/00201, MA1047/00202
Country: NL	Z-Index G-Standaard	Identifier(s): 14281244
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 62464, 62472
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10039, 10040, 14564
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100023736, 100195220, 100427356
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W62498001, W62498002, W62499001, W62499002, W62499003, W62499004, W62499005
Country: SG	Health Sciences Authority	Identifier(s): 10886P, 10889P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 10623041H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681429550073, 8681429550363
Country: ZA	Health Products Regulatory Authority	Identifier(s): T/30.3/597, T/30.3/598